当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析

康泰医学

(300869)

  

流通市值:32.70亿  总市值:52.23亿
流通股本:2.52亿   总股本:4.02亿

康泰医学(300869)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.10亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益193344.76万元,未分配利润98021.20万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产283259.32万元,负债89914.56万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入333,885,288.03211,789,804.5299,175,164.46746,902,140.39
营业总成本336,662,644.47212,974,691.76102,176,199.13568,889,907.42
营业利润10,472,484.727,906,278.512,807,644.45186,734,053.22
利润总额11,158,450.988,504,332.323,119,219.51186,125,825.61
净利润9,902,927.868,167,120.794,351,935.11165,765,985.8
其他综合收益-713,854.7978,993.98-135,263.53761,799.6
综合收益总额9,189,073.078,246,114.774,216,671.58166,527,785.4
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,851,736,075.881,869,207,101.022,150,686,350.482,482,164,235.52
非流动资产合计980,857,146.66965,619,493.36947,578,191.73729,782,416.65
资产总计2,832,593,222.542,834,826,594.383,098,264,542.213,211,946,652.17
流动负债合计173,434,791.67179,457,714.33333,596,329.15459,938,077.63
非流动负债合计725,710,815.79722,864,223.27715,652,570707,211,885.26
负债合计899,145,607.46902,321,937.61,049,248,899.151,167,149,962.89
归属于母公司股东权益合计1,933,447,615.081,932,504,656.782,049,015,643.062,044,796,689.28
股东权益合计1,933,447,615.081,932,504,656.782,049,015,643.062,044,796,689.28
负债和股东权益合计2,832,593,222.542,834,826,594.383,098,264,542.213,211,946,652.17
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计362,833,774.81237,030,254.24110,319,968.53989,163,696.49
经营活动现金流出小计327,640,769.58223,165,786.6110,866,407.97808,148,976.06
经营活动产生的现金流量净额35,193,005.2313,864,467.64-546,439.44181,014,720.43
投资活动现金流入小计4,377,891,221.283,023,454,927.61,254,098,774.06167,777,527.28
投资活动现金流出小计3,969,575,972.462,617,539,347.99973,982,712.86890,735,599.29
投资活动产生的现金流量净额408,315,248.82405,915,579.61280,116,061.2-722,958,072.01
筹资活动现金流入小计90,000,00090,000,000143,160,301.371,077,878,400
筹资活动现金流出小计476,682,802.77475,884,145.94142,278,214.921,461,317,612.45
筹资活动产生的现金流量净额-386,682,802.77-385,884,145.94882,086.45-383,439,212.45
汇率变动对现金及现金等价物的影响-5,475,666.142,899,452.821,898,965.285,282,712.7
现金及现金等价物净增加额51,349,785.1436,795,354.13282,350,673.49-920,099,851.33
期末现金及现金等价物余额518,573,031.87504,018,600.86749,573,920.22467,223,246.73
TOP↑